Cathy Quelen

1.3k total citations
20 papers, 627 citations indexed

About

Cathy Quelen is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Cathy Quelen has authored 20 papers receiving a total of 627 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Pathology and Forensic Medicine and 6 papers in Immunology. Recurrent topics in Cathy Quelen's work include Immune Cell Function and Interaction (5 papers), Lymphoma Diagnosis and Treatment (5 papers) and RNA modifications and cancer (4 papers). Cathy Quelen is often cited by papers focused on Immune Cell Function and Interaction (5 papers), Lymphoma Diagnosis and Treatment (5 papers) and RNA modifications and cancer (4 papers). Cathy Quelen collaborates with scholars based in France, Italy and Belgium. Cathy Quelen's co-authors include Pierre Brousset, Marina Bousquet, Nicole Dastugue, Cyril Broccardo, Fabienne Meggetto, Cécile Demur, Éric Delabesse, Laurence Lamant, Georges Delsol and Xabier Agirre and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Blood.

In The Last Decade

Cathy Quelen

20 papers receiving 623 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cathy Quelen France 14 395 199 157 115 110 20 627
Stéphanie Struski France 16 264 0.7× 84 0.4× 171 1.1× 134 1.2× 112 1.0× 30 596
Marian Stevens‐Kroef Netherlands 14 366 0.9× 133 0.7× 396 2.5× 115 1.0× 153 1.4× 30 692
Daniel Trageser United States 6 277 0.7× 141 0.7× 124 0.8× 201 1.7× 190 1.7× 8 629
Tim Ripperger Germany 15 341 0.9× 215 1.1× 125 0.8× 68 0.6× 135 1.2× 46 756
Helen Cattan United Kingdom 5 488 1.2× 284 1.4× 283 1.8× 164 1.4× 78 0.7× 7 736
T Flores Spain 9 232 0.6× 90 0.5× 124 0.8× 112 1.0× 228 2.1× 21 570
Mauro Nanni Italy 16 402 1.0× 113 0.6× 456 2.9× 294 2.6× 86 0.8× 43 804
Florence Armstrong France 10 290 0.7× 79 0.4× 180 1.1× 82 0.7× 171 1.6× 12 630
Holger Kohlhammer Germany 9 393 1.0× 168 0.8× 95 0.6× 103 0.9× 203 1.8× 11 721
Jinlan Pan China 13 234 0.6× 63 0.3× 369 2.4× 177 1.5× 68 0.6× 104 603

Countries citing papers authored by Cathy Quelen

Since Specialization
Citations

This map shows the geographic impact of Cathy Quelen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cathy Quelen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cathy Quelen more than expected).

Fields of papers citing papers by Cathy Quelen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cathy Quelen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cathy Quelen. The network helps show where Cathy Quelen may publish in the future.

Co-authorship network of co-authors of Cathy Quelen

This figure shows the co-authorship network connecting the top 25 collaborators of Cathy Quelen. A scholar is included among the top collaborators of Cathy Quelen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cathy Quelen. Cathy Quelen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gravelle, Pauline, Juan García Valero, Nathalie Van Acker, et al.. (2023). Patient-derived lymphoma spheroids integrating immune tumor microenvironment as preclinical follicular lymphoma models for personalized medicine. Journal for ImmunoTherapy of Cancer. 11(10). e007156–e007156. 9 indexed citations
2.
Quelen, Cathy, David Grand, Émeline Sarot, et al.. (2020). Minimal Residual Disease Monitoring Using a 3′ALK Universal Probe Assay in ALK-Positive Anaplastic Large-Cell Lymphoma. Journal of Molecular Diagnostics. 23(2). 131–139. 11 indexed citations
4.
Hoareau‐Aveilla, Coralie, Cathy Quelen, Delphine Labourdette, et al.. (2018). miR-497 suppresses cycle progression through an axis involving CDK6 in ALK-positive cells. Haematologica. 104(2). 347–359. 23 indexed citations
5.
Pasquet, Marlène, Nelly Rouquié, Naïs Prade, et al.. (2018). PAX5-ELN oncoprotein promotes multistep B-cell acute lymphoblastic leukemia in mice. Proceedings of the National Academy of Sciences. 115(41). 10357–10362. 18 indexed citations
6.
Ducassou, Stéphane, Valérie Prouzet‐Mauleon, Marie‐Céline Deau, et al.. (2017). MYB–GATA1 fusion promotes basophilic leukaemia: involvement of interleukin‐33 and nerve growth factor receptors. The Journal of Pathology. 242(3). 347–357. 10 indexed citations
7.
Philippe, Céline, Alexandre Dubrac, Cathy Quelen, et al.. (2016). PERK mediates the IRES-dependent translational activation of mRNAs encoding angiogenic growth factors after ischemic stress. Science Signaling. 9(426). ra44–ra44. 35 indexed citations
8.
Hoareau‐Aveilla, Coralie, Thibaud Valentin, Cathy Quelen, et al.. (2015). Reversal of microRNA-150 silencing disadvantages crizotinib-resistant NPM-ALK(+) cell growth. Journal of Clinical Investigation. 125(9). 3505–3518. 34 indexed citations
9.
Vaysse, Charlotte, Céline Philippe, Yvan Martineau, et al.. (2015). Key contribution of eIF4H-mediated translational control in tumor promotion. Oncotarget. 6(37). 39924–39940. 30 indexed citations
10.
Puisségur, Marie-Pierre, Ruth Eichner, Cathy Quelen, et al.. (2012). B-cell regulator of immunoglobulin heavy-chain transcription (Bright)/ARID3a is a direct target of the oncomir microRNA-125b in progenitor B-cells. Leukemia. 26(10). 2224–2232. 47 indexed citations
11.
Laprévotte, Emilie, Emilie‐Fleur Gautier, Cathy Quelen, et al.. (2012). Specific small nucleolar RNA expression profiles in acute leukemia. Leukemia. 26(9). 2052–2060. 103 indexed citations
12.
Quelen, Cathy. (2012). Acute basophilic leukemia - t(X;6)(p11;q23). Atlas of Genetics and Cytogenetics in Oncology and Haematology. 1 indexed citations
13.
Ysebaert, Loïc, Virginie Fataccioli, Cathy Quelen, et al.. (2012). Small Nucleolar RNA Expression Profiling Identifies Potential Prognostic Markers in Peripheral T-Cell Lymphoma.. Blood. 120(21). 2678–2678. 1 indexed citations
14.
Ysebaert, Loïc, Virginie Fataccioli, Cathy Quelen, et al.. (2012). Small nucleolar RNA expression profiling identifies potential prognostic markers in peripheral T-cell lymphoma. Blood. 120(19). 3997–4005. 60 indexed citations
15.
Quelen, Cathy, Éric Lippert, Stéphanie Struski, et al.. (2011). Identification of a transforming MYB-GATA1 fusion gene in acute basophilic leukemia: a new entity in male infants. Blood. 117(21). 5719–5722. 29 indexed citations
16.
Vassallo, José, et al.. (2007). CD5-positive diffuse large B cell lymphoma arising from a CD5-positive follicular lymphoma. Journal of Clinical Pathology. 60(5). 573–575. 6 indexed citations
18.
Bousquet, Marina, Cyril Broccardo, Cathy Quelen, et al.. (2006). A novel PAX5-ELN fusion protein identified in B-cell acute lymphoblastic leukemia acts as a dominant negative on wild-type PAX5. Blood. 109(8). 3417–3423. 70 indexed citations
19.
Bousquet, Marina, Cathy Quelen, Véronique Mansat‐De Mas, et al.. (2005). The t(8;9)(p22;p24) translocation in atypical chronic myeloid leukaemia yields a new PCM1-JAK2 fusion gene. Oncogene. 24(48). 7248–7252. 85 indexed citations
20.
Bousquet, Marina, Christian Récher, Cathy Quelen, et al.. (2005). Assessment of somatic mutations in phosphatidylinositol 3‐kinase gene in human lymphoma and acute leukaemia. British Journal of Haematology. 131(3). 411–413. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026